Got $2,000: Invest in These 2 Cheap TSX Stocks to Double Your Money

Despite their near-term risks, both BlackBerry and Canopy Growth offer strong long-term growth potential.

| More on:
Money growing in soil , Business success concept.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The Canadian financial markets have recovered strongly from their March lows. However, some of the stocks are still struggling and are trading at attractive valuations. So, if you have the appetite for risk-taking and can stay invested for extended periods, I believe these two stocks could deliver huge profits.

BlackBerry

When the majority of the tech companies have delivered excellent returns this year, BlackBerry (TSX:BB)(NYSE:BB) is struggling with its stock, trading over 24% lower. The company’s significant exposure to the automotive industry impacted its financials in its recently completed first quarter.

Its adjusted revenue declined by 19.9% on a year-over-year basis. The global auto production shutdowns and project delays amid the pandemic had dragged the company’s revenue down. However, with the reopening of the economies, the auto sector is beginning to recover.

The company also provides cybersecurity solutions for companies across various sectors. With the rise in the number of employees working from their homes, the demand for data safety and privacy solutions has increased, which could benefit BlackBerry.

At the end of its first quarter, the company’s cash, cash equivalents, and investments stood at US$955 million. Further, the company’s management expects its free cash flow to be positive for this fiscal year. So, the company’s liquidity position looks secure. Given its attractive valuation, strong balance sheet, and growth prospects, I believe investors with a long-term horizon should buy the stock for higher gains.

Canopy Growth

My second pick is a cannabis company Canopy Growth (TSX:WEED)(NYSE:CGC), which has lost over 20% of its stock value this year. Although the cannabis sector is facing structural issues, the company had outperformed analysts’ sales expectations in its recently reported first-quarter results.

Its revenues came in at $110.4 million against analysts’ expectations of $93.5 million. The growth in medical sales offset the decline in recreational sales to drive the company’s revenue. The increased competition and the temporary closure of retail stores due to the pandemic dragged the company’s recreational sales down.

However, Canopy Growth has re-positioned its value brand Tweed dried flower with higher and more consistent THC ranges and is working on expanding its Cannabis 2.0 offerings in Canada to drive its recreational sales. In the United States, the company has increased its online presence by launching an e-commerce site, which sells all brands of CBD products from Canopy growth.

The company has also scaled up the distribution of its S&B vaporizer and BioSteel RTD non-CBD beverages to some of the key markets in the United States. All these initiatives could drive the company’s top line.

Meanwhile, its adjusted EBITDA is still in negative territory, which is a cause of concern. The company is working on lowering its expenditures. Year to date, the company has reduced its headcount by 18%. Further, it has optimized its production by closing two of its facilities in British Columbia and one indoor facility in Saskatchewan. Along with these cost-cutting initiatives, the growth in higher-margin Cannabis 2.0 product sales could aid the company in attaining profitability.

Moreover, in its first quarter, the company reduced its cash burn by 50% to $180.1 million. At the end of the quarter, the company’s gross cash stood at $2 billion. So, given its strong growth potential, improving margins, and strong balance sheet, I believe Canopy Growth’s stock could double over the next three years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends BlackBerry and BlackBerry. Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »